Amsurg Corp. (AMSG) Shares Bought by Cardinal Capital Management
Cardinal Capital Management raised its position in shares of Amsurg Corp. (NASDAQ:AMSG) by 3.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,051 shares of the company’s stock after buying an additional 251 shares during the period. Cardinal Capital Management’s holdings in Amsurg Corp. were worth $547,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of AMSG. Redwood Investments LLC increased its position in shares of Amsurg Corp. by 27.4% in the second quarter. Redwood Investments LLC now owns 62,595 shares of the company’s stock worth $4,854,000 after buying an additional 13,450 shares in the last quarter. Capital Fund Management S.A. increased its position in shares of Amsurg Corp. by 42.9% in the second quarter. Capital Fund Management S.A. now owns 9,634 shares of the company’s stock worth $747,000 after buying an additional 2,893 shares in the last quarter. Chase Investment Counsel Corp acquired a new position in shares of Amsurg Corp. during the second quarter worth approximately $876,000. Retirement Systems of Alabama increased its position in shares of Amsurg Corp. by 1.0% in the second quarter. Retirement Systems of Alabama now owns 69,743 shares of the company’s stock worth $5,408,000 after buying an additional 679 shares in the last quarter. Finally, Moody Aldrich Partners LLC increased its position in shares of Amsurg Corp. by 116.5% in the second quarter. Moody Aldrich Partners LLC now owns 8,615 shares of the company’s stock worth $668,000 after buying an additional 4,635 shares in the last quarter. 98.42% of the stock is owned by hedge funds and other institutional investors.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded down 0.71% during mid-day trading on Tuesday, hitting $65.79. The stock had a trading volume of 888,657 shares. Amsurg Corp. has a one year low of $58.37 and a one year high of $87.29. The stock has a market cap of $3.54 billion, a price-to-earnings ratio of 19.52 and a beta of 0.68. The firm has a 50 day moving average of $65.44 and a 200 day moving average of $73.48.
Amsurg Corp. (NASDAQ:AMSG) last posted its earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The company had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. During the same period last year, the company earned $0.97 earnings per share. The business’s revenue was up 21.5% compared to the same quarter last year. On average, analysts forecast that Amsurg Corp. will post $4.33 earnings per share for the current year.
Several analysts have issued reports on the company. KeyCorp restated a “positive” rating and set a $87.00 price objective on shares of Amsurg Corp. in a research note on Tuesday. Citigroup Inc. assumed coverage on Amsurg Corp. in a research note on Monday, September 26th. They set a “buy” rating and a $79.00 price objective on the stock. Zacks Investment Research cut Amsurg Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price objective on shares of Amsurg Corp. in a research note on Thursday, July 14th. Finally, Jefferies Group restated a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $92.09.
In other news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $63.65, for a total value of $477,375.00. Following the sale, the insider now directly owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 2.30% of the stock is owned by insiders.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.